
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 18, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 18, 2024
Language: Английский
Probiotics and Antimicrobial Proteins, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 19, 2025
Abstract The pathogenicity of Staphylococcus aureus is largely regulated by the agr quorum sensing (QS) system encoded agrBDCA , which coordinates virulence factor production through secretion and auto-inducing peptides (AIPs). -like systems are also present in coagulase-negative staphylococci, several these encode AIPs that inhibit S. QS. In lactic acid bacteria, a similar locus was previously identified Lactiplantibacillus plantarum WCSF1 termed lamBDCA . Here, we characterized L. LMG 13556 paraplantarum CIRM-BIA 1870, explored effects on Notably, found co-cultivation with significantly inhibits QS hemolysin production, while less so for inhibition lost upon disruption its locus, suggesting AIP mediates cross-species interference activation. Transcriptomic analysis revealed controls expression genes belonging to various functional categories, including stress response metabolism. latter includes encoding riboflavin (B2 vitamin) biosynthesis, enabled growth lamB mutant presence roseoflavin, toxic analogue. Collectively, our results show 1870 interferes gene suppression, they implicate probiotic properties
Language: Английский
Citations
0Antimicrobial Agents and Chemotherapy, Journal Year: 2025, Volume and Issue: unknown
Published: March 14, 2025
ABSTRACT Antibiotic resistance, driven by misuse and overuse of antibiotics, is one the greatest threats against human health. The antimicrobial pressure during prolonged antibiotic treatment chronic bacterial infections selects for resistance. While combinations may reduce resistance emergence, antibiotic-tolerant persister cells can serve as a reservoir development. Therefore, targeting these with anti-persister drugs might provide novel strategy prevention. In this study, we conducted 42 days adaptive laboratory evolution using Staphylococcus aureus exposed to rifampicin, ciprofloxacin, daptomycin, vancomycin, alone or in combination drug mitomycin C. We monitored susceptibility daily assessed phenotypic changes growth biofilm formation evolved strains. Whole-genome sequencing revealed mutations linked shifts. Rifampicin developed within few days, while ciprofloxacin daptomycin emerged approximately 3 weeks. Treatments vancomycin C resulted minimal susceptibility. therapy delayed it did not fully prevent it. Notably, rifampicin maintained throughout long-term experiment. Sub-inhibitory treatments selected both previously characterized mutations, including unprecedented alterations nucleotide excision repair system azoreductase following exposure. development observed therapy, particularly C’s ability suppress suggests potential therapeutic applications. Future studies should evaluate clinical efficacy preventing across different pathogens infection models.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: April 23, 2025
Language: Английский
Citations
0Antibiotics, Journal Year: 2025, Volume and Issue: 14(5), P. 470 - 470
Published: May 6, 2025
Staphylococcus aureus is a formidable human pathogen responsible for infections ranging from superficial skin lesions to life-threatening systemic diseases. This review synthesizes current knowledge on its pathogenesis, emphasizing colonization dynamics, virulence mechanisms, biofilm formation, and antibiotic resistance. By analyzing studies PubMed, Scopus, Web of Science, we highlight the pathogen’s adaptability, driven by surface adhesins (e.g., ClfB, SasG), secreted toxins PVL, TSST-1), metabolic flexibility in iron acquisition amino acid utilization. Nasal, skin, oropharyngeal are reservoirs invasive infections, with persistence horizontal gene transfer exacerbating antimicrobial resistance, particularly methicillin-resistant S. (MRSA). The underscores clinical challenges multidrug-resistant strains, including vancomycin resistance decolonization strategies’ failure target single anatomical sites. Key discussions address host–microbiome interactions, immune evasion tactics, limitations therapies. Future directions advocate novel anti-virulence therapies, multi-epitope vaccines, AI-driven diagnostics combat evolving Strengthening global surveillance interdisciplinary collaboration critical mitigating public health burden aureus.
Language: Английский
Citations
0bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 17, 2024
Abstract Antibiotic resistance is one of the greatest threats against human health and misuse overuse antibiotics a key factor driving development. During prolonged antibiotic treatment chronic infections, antimicrobial pressure facilitates selection mutations. It has been suggested that using in combinations may reduce emergence resistance. Furthermore, tolerant persister cells be reservoir for development, so targeting with anti-persister drugs could also In this study, we conducted 42-day adaptive laboratory evolution experiment Staphylococcus aureus exposed to common drug mitomycin C, either alone or combination. We monitored susceptibility daily assessed phenotypic changes growth biofilm formation evolved strains. Whole-genome sequencing revealed mutations linked shifts. Resistance developed rapidly rifampicin, while ciprofloxacin daptomycin showed slower emergence. Treatments vancomycin C resulted minimal susceptibility. Combination therapies generally delayed resistance, though was not fully prevented. Notably, combined rifampicin effectively suppressed Sub-inhibitory concentrations were associated both known novel mutations, including nucleotide excision repair system azoreductase, following treatment—mutations previously reported. While combination therapy C’s efficacy ability prevent highlights its potential combating Further investigation needed evaluate broader application prevention.
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 18, 2024
Language: Английский
Citations
0